FDABridge
العودة إلى المدوّنة →
عام

FDA 이야기 #014 — 폴란드 냉동 피에로기 제조업체에 알레르기 유발 물질 표시가 전혀 없었다

제품은 인도에서 제조되어 두바이로 보내져 재포장된 후 'Product of UAE' 라벨로 미국에 수출되었습니다. 원산지 표시는 그렇게 작동하지 않습니다.

فريق FDABridge١ يناير ٢٠٢٦2 دقائق قراءة

A trading company in Dubai imported bulk spice blends from a manufacturer in Rajasthan, India. In Dubai, they repackaged the spices into retail-sized containers, applied their own brand label, and exported to the United States. The label said 'Product of UAE.'

The product was not a product of the UAE.

문제

Under 19 CFR Part 134, the country of origin is the country where the product was manufactured or where the last substantial transformation occurred. Repackaging — transferring a product from bulk bags into smaller retail containers — is not substantial transformation. The spices were grown, processed, and blended in India. Putting them into smaller bags in Dubai does not change the country of origin. The correct marking was 'Product of India,' regardless of where the repackaging occurred.

US Customs and Border Protection enforces country of origin marking, and the penalties are real: a 10 percent ad valorem marking duty on improperly marked goods, plus the cost of re-marking or re-labeling the entire shipment before it can be released.

문제

The Indian manufacturer had an FDA food facility registration. The Dubai repackaging facility did not — and it needed one, because it was packing food for US consumption. Additionally, the Dubai facility's label used the Indian manufacturer's FDA registration number, which was incorrect because the registration number identifies a specific facility, and the repackaging was happening at a different facility.

We registered the Dubai facility with the FDA, obtained a DUNS number for the Dubai operation, corrected the country of origin to 'Product of India,' and updated the FDA registration number on the label to reflect the repackaging facility. The Indian manufacturer's registration remained active for their facility — both registrations were needed because both facilities were involved in preparing the product for US sale.

교훈

If you buy products from one country, repackage them in another, and export to the US — the country of origin is where the product was made, not where it was repackaged. And both facilities may need FDA registration. This is especially common in Dubai, Singapore, Hong Kong, and other trading hubs. If your supply chain crosses borders, make sure every facility is registered and every label is marked correctly. fdabridge.com/contact.

تحتاج مساعدة في الخطوة التالية؟

هل تحتاج مساعدة في اختيار خدمة؟

قارن الخيارات الرئيسية واختر المسار المناسب لفئة منتجك.

المزيد للقراءة

مقالات ذات صلة

عام

علامات وضع العلامات على الأجهزة الطبية: ما يجب أن يعرفه المصنعون الأجانب لدخول السوق الأمريكية

٢٨ أبريل ٢٠٢٦

تطلب وضع علامات على الأجهزة الطبية في الولايات المتحدة رموز محددة للتواصل الصحيح. يجب على المصنعين الأجانب فهم معايير الرموز التي اعتمدتها إدارة الأغذية والعقاقير قبل تصدير الأجهزة إلى السوق الأمريكية.

اقرأ المزيد ←
عام

تسجيل الأجهزة الطبية للصناع الأجنبي: دليل على نظام التنظيم في الولايات المتحدة

٢٦ مارس ٢٠٢٦

يجب على صانعي الأجهزة الطبية الأجنبية تسجيل مؤسساتهم، وإدراج أجهزتها، و اعتمادا على فئة الأجهزة الحصول على تصريح أو موافقة من الوكالة قبل توزيعها في الولايات المتحدة.

اقرأ المزيد ←
عام

عشرة أسئلة يجب أن تسألها قبل توظيف مستشار في إدارة الأغذية والعقاقير

٢٤ مايو ٢٠٢٦

اختيار مزود خدمة الامتثال لـ FDA هو قرار كبير هذه الأسئلة العشرة تساعد المصنعين الأجانب على فصل المستشارين المهرة من أولئك الذين سيخلقون مشاكل لا يمكنهم إصلاحها.

اقرأ المزيد ←